Dark Streaming/Mobile Old Site Home Products Help Contact Us Your Account System Status
Sign-up for a FREE 30-day Stockwatch subscription and SEE NO ADS
19:28:25 EDT Wed 01 May 2024
Enter Symbol
or Name
USA
CA



Z:DHR - DANAHER CORP - http://www.danaher.com
Sym-XBid - AskLastChg%ChVol$Vol#TrOpen-Hi-LoYear Hi-LoLast TrNewsDelay
DHR - Z9.9246.74·251.011.9246.995+0.3750.22,310.1566,98224,644245.8059  249.52  244.55259.00  182.0917:32:54Apr 2315 min RT 2¢

Recent Trades - Last 10 of 24644
Time ETExPriceChangeVolume
17:32:54Z246.890.2717,700
17:01:38Z247.030.415
16:15:04Z246.890.271
16:05:51Z246.890.272,497
16:04:52Z246.890.271,893
16:01:51Z246.890.2744
16:01:49Z246.890.2783,000
16:01:30Z250.003.3810
16:01:23Z246.890.27364
16:01:19Z246.890.2710,488

Sign-up for a FREE 30-day Stockwatch subscription and SEE NO ADS

Recent Bulletins
Date ETSymbolTypeHeadline
2024-04-23 06:00U:DHRNews ReleaseDanaher Reports First Quarter 2024 Results
2024-03-21 16:15U:DHRNews ReleaseDanaher Schedules First Quarter 2024 Earnings Conference Call
2024-02-27 16:15U:DHRNews ReleaseDanaher to Present at TD Cowen Health Care Conference
2024-02-22 16:15U:DHRNews ReleaseDanaher Commits to Set Science-Based, Net-Zero Greenhouse Gas Emission Reduction Targets
2024-02-21 16:15U:DHRNews ReleaseDanaher Announces Quarterly Dividend
2024-02-05 07:30U:DHRNews ReleaseDanaher Launches Collaboration with Cincinnati Children's Hospital Medical Center Aiming to Improve Patient Safety in Early Drug Development
2024-01-30 06:00U:DHRNews ReleaseDanaher Reports Fourth Quarter and Full Year 2023 Results
2024-01-09 07:30U:DHRNews ReleaseDanaher, Jennifer Doudna, and Innovative Genomics Institute Launch Danaher-IGI Beacon for CRISPR Cures with Aim to Address Hundreds of Diseases Using Gene-editing Platform Solution
2024-01-08 16:15U:DHRNews ReleaseDanaher CEO to Comment on Financial Performance
2024-01-02 17:00U:DHRNews ReleaseDanaher to Present at J.P. Morgan Healthcare Conference
2023-12-21 16:30U:DHRNews ReleaseDanaher Schedules Fourth Quarter 2023 Earnings Conference Call
2023-12-13 16:06U:DHRNews ReleaseCodexis and Aldevron Enter Exclusive Licensing Agreement for Codex ‚ ® HiCap RNA Polymerase
2023-12-06 07:30U:DHRNews ReleaseDanaher Completes Acquisition of Abcam
2023-12-05 16:30U:DHRNews ReleaseDanaher Announces Quarterly Dividend
2023-11-21 16:15U:DHRNews ReleaseDanaher to Present at Evercore ISI HealthCONx Conference
2023-10-31 07:30U:DHRNews ReleaseDanaher appoints Christopher Riley to Executive Vice President for Biotechnology
2023-10-24 06:00U:DHRNews ReleaseDanaher Reports Third Quarter 2023 Results
2023-09-30 08:00U:DHRNews ReleaseDanaher Corporation Completes Separation of Veralto Corporation
2023-09-26 16:15U:DHRNews ReleaseDanaher Schedules Third Quarter 2023 Earnings Conference Call
2023-09-19 07:43U:DHRNews ReleaseDanaher to Provide Cepheid's Tuberculosis Test to the Global Fund at Cost